179324-69-7 VELCADE dpba
Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other medication. Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system) who have already been treated with at least one other medication. Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells.
Item |
Specifications |
Results |
Appearance |
White or almost white |
Pass |
Purity |
≥99.0% |
99.8% |
Specific Rotation |
-45°~ -55° |
-54.4° |
Related Substances |
Single Impurity≤0.10% Total Impurity≤0.10%
|
Pass |
Residual Solvents |
Dichloromethane≤0.06% Hexane≤0.029% Ethyl Acetate≤0.5% |
Pass |
Loss on drying |
≤1.0% |
0.48% |
Heavy Metals |
≤20ppm |
Pass |
Conclusion |
The test conforms to the specification of Enterprise standard |
CAS NO:4337-33-1
CAS NO:108-59-8
CAS NO:104206-65-7
CAS NO:439081-18-2
CAS NO:439081-18-2
CAS NO:439081-18-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View